The rising prevalence in GLP-1 agonists for metabolic conditions has led to a debate about application forms : skin-applied devices versus tablets . Typically, GLP-1 therapies were solely available in pill form, but the introduction of skin applications provides a new way. Patches might benefit individuals with difficulty with oral medications, … Read More